Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerald P Radich

Showing results (21-30 of 208) with videos related to

Pageof 21
Sort By:
Clinical Lymphoma & Myeloma|March 27, 2007
Monitoring patients with chronic myeloid leukemia receiving Abl tyrosine kinase inhibitor therapyVivian Oehler, Jerald P Radich
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2007
Monitoring chronic myelogenous leukemia in the age of tyrosine kinase inhibitorsJerald P Radich, Vivian Oehler
Hematology (Amsterdam, Netherlands)|June 16, 2001
Malignancy: Tumor Suppressor Gene Aberrations in Acute Myelogenous LeukemiaDEREK L. Stirewalt, JERALD P. Radich
Current Oncology Reports|August 5, 2003
Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemiaVivian G Oehler, Jerald P Radich
Hematology/Oncology Clinics of North America|July 5, 2017
Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid LeukemiaJerald P Radich, Michael J Mauro
Nature Reviews. Cancer|September 3, 2003
The role of FLT3 in haematopoietic malignanciesDerek L Stirewalt, Jerald P Radich
Blood|July 8, 2017
CHIPs and engraftment dipsFrederick R Appelbaum, Jerald P Radich
Current Hematologic Malignancy Reports|April 29, 2010
Monitoring BCR-ABL in the treatment of chronic myeloid leukemia by polymerase chain reactionVivian G Oehler, Jerald P Radich
Blood|July 14, 2012
Pretransplant MRD: the light is yellow, not redAlan S Wayne, Jerald P Radich
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2014
Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutationDaniel N Egan, Lan Beppu, Jerald P Radich
Pageof 21

Showing results (21-30 of 208) with videos related to

Sort By:
Pageof 21
Clinical Lymphoma & Myeloma|March 27, 2007
Monitoring patients with chronic myeloid leukemia receiving Abl tyrosine kinase inhibitor therapyVivian Oehler, Jerald P Radich
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2007
Monitoring chronic myelogenous leukemia in the age of tyrosine kinase inhibitorsJerald P Radich, Vivian Oehler
Hematology (Amsterdam, Netherlands)|June 16, 2001
Malignancy: Tumor Suppressor Gene Aberrations in Acute Myelogenous LeukemiaDEREK L. Stirewalt, JERALD P. Radich
Current Oncology Reports|August 5, 2003
Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemiaVivian G Oehler, Jerald P Radich
Hematology/Oncology Clinics of North America|July 5, 2017
Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid LeukemiaJerald P Radich, Michael J Mauro
Nature Reviews. Cancer|September 3, 2003
The role of FLT3 in haematopoietic malignanciesDerek L Stirewalt, Jerald P Radich
Blood|July 8, 2017
CHIPs and engraftment dipsFrederick R Appelbaum, Jerald P Radich
Current Hematologic Malignancy Reports|April 29, 2010
Monitoring BCR-ABL in the treatment of chronic myeloid leukemia by polymerase chain reactionVivian G Oehler, Jerald P Radich
Blood|July 14, 2012
Pretransplant MRD: the light is yellow, not redAlan S Wayne, Jerald P Radich
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2014
Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutationDaniel N Egan, Lan Beppu, Jerald P Radich
Pageof 21